FDA OKs New Antipsychotic for Schizophrenia, Bipolar Disorder

(MedPage Today) -- The FDA approved the antipsychotic combination of olanzapine plus samidorphan (Lybalvi) for adults with schizophrenia or bipolar I disorder, drugmaker Alkermes announced on Tuesday.
In schizophrenia, olanzapine-samidorphan is...